Medicine and Dentistry
Transplantation
100%
Kidney Graft
82%
Kidney Transplantation
73%
COVID-19
60%
Biopsy
32%
Allograft
30%
Kidney Allograft
25%
Graft Failure
25%
Nephropathy
22%
Antibody Mediated Rejection
20%
Immunosuppressive Treatment
19%
Acute Graft Rejection
16%
Infection
16%
Injury
16%
Solid Organ Transplantation
16%
Gender and Sex
16%
Chronic Kidney Disease
14%
Nephrology
14%
Biological Marker
13%
Kidney Function
12%
Virus Infection
12%
Retrospective Cohort Study
12%
Nephrologist
11%
Organ Transplantation
11%
Graft Survival
11%
Antibodies
11%
Hazard Ratio
10%
Hemodialysis
10%
Clinical Trial
10%
Creatinine
10%
Dialysis Catheter
9%
Cell-Free DNA
9%
Disease
9%
Graft Rejection
8%
Organ Donor
8%
Drug Therapy
8%
Immunosuppressive Drug
8%
Prospective Study
8%
Immune Disorder
8%
Odds Ratio
7%
Cytochrome P450 3A5
7%
Pandemic
7%
Kidney Graft Rejection
7%
Human Immunodeficiency Virus Infection
7%
Liver Graft
7%
T Cell
7%
BK Virus
7%
Clazakizumab
7%
Malignant Neoplasm
7%
Observational Study
7%
Prevalence
7%
Diagnosis
6%
Reproducibility
6%
Glomerular Filtration Rate
6%
Computer Assisted Tomography
6%
Glomerulonephritis
6%
Preoperative Evaluation
6%
Eculizumab
6%
Diagnostic Accuracy
6%
Kidney Dysfunction
6%
Next Generation Sequencing
6%
Immunoglobulin
6%
COVID-19 Vaccination
6%
Transplantation Research
6%
Medicine
6%
Viremia
5%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
Allele
5%
Acute Kidney Injury
5%
Tacrolimus
5%
Renal Replacement Therapy
5%
Cancer
5%
Epileptic Absence
5%
Keyphrases
Kidney Transplant Recipients
29%
Kidney Transplantation
26%
COVID-19
18%
Coronavirus Disease (COVID)
16%
Kidney Transplant
12%
Solid Organ Transplant Recipients
12%
Transplantation
12%
Tacrolimus
10%
COVID-19 Outcomes
9%
Solid Organ Transplantation
9%
Mouse Model
9%
Graft Function
9%
Chronic Antibody-mediated Rejection
9%
Graft Loss
8%
United States
8%
Major Adverse Renal Events
8%
Allograft
8%
Genotype
8%
BK Viremia
8%
Fibrosis
8%
Living Donor Kidney Transplantation
8%
Inflammation
7%
Retrospective Cohort Study
7%
Clazakizumab
7%
Serum Creatinine
7%
CYP3A5
7%
Kidney Transplant Outcomes
7%
Kidney Transplant Rejection
6%
Viral Infection
6%
Transplant Outcomes
6%
Solid Organ Transplant
6%
Death-censored Graft Survival
6%
Next-generation Sequencing
6%
Kidney Allocation
6%
Immune Dysfunction
6%
Prospective Observational Study
6%
Expert Recommendation
6%
Transplanting Time
6%
BK Polyomavirus (BKPyV)
6%
Natural History
6%
Expert Review
6%
Chronic Allograft Injury
6%
Multicenter Prospective Study
6%
Area under the Curve
6%
MiRNA Signature
6%
Sex Equity
6%
Blood RNA
6%
Evaluation History
6%
COVID-19 Breakthrough Infections
6%
SARS-CoV-2 Vaccination
6%
Clinical Outcomes
6%
Adverse Cardiac Events
6%
Clinical Trials
5%
Kidney
5%
Immunosuppressive Therapy
5%
Immunosuppression
5%
Chronic Kidney Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
27%
Infection
22%
Tacrolimus
19%
Hemodialysis
19%
Coronavirinae
19%
Cohort Study
19%
Kidney Disease
17%
Clinical Trial
15%
Mouse Model
12%
Chronic Kidney Failure
11%
Immunosuppressive Agent
11%
Graft Failure
10%
Vaccination Policy
9%
Virus Infection
8%
Malignant Neoplasm
8%
Thymocyte Antibody
8%
Creatinine
8%
SARS Coronavirus
7%
Acute Kidney Failure
7%
Nephrotoxicity
7%
Cytochrome P450 3A5
6%
Rapamycin
6%
Rituximab
6%
Crackle
6%
HIV
6%
BK Virus
6%
Prospective Study
6%
Statin (Protein)
6%
Arteriovenous Fistula
6%
Cinacalcet
6%
Cetuximab
6%
Clazakizumab
6%
Focal Glomerulosclerosis
6%
Doxorubicin
6%
Comorbidity
5%
Human Immunodeficiency Virus Infection
5%
Viremia
5%
Side Effect
5%